ARCHIVES

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA Seeks Applicants For Oncology Div. Head; Croce Wins Pasarow Award; CRI Honors Five

August 18, 1995

Obituary: Sydney Salmon, 63, Founding Director, Arizona Cancer Center

October 15, 1999

CDC To Award $23 Mil. To States for Screening

April 26, 1991

Competing Core, P01 Grants Held To 7% Increases To Help Spread $$ Around

December 7, 1979

Oral Capecitabine Equal To 5FU-Leucovorin In Adjuvant Stage III Colon Cancer Treatment

June 25, 2004

Fur New Centers Funded In ’88; More New Consortia On Way

November 25, 1988